Skip to content
★ Sign in to follow
로킷

로킷헬스케어 Stock: price and insider trades · South Korea

KR·Mcap ₩345.1BHealth Care

No insider purchase over the last 90 days. The latest, by 이영일, was filed 21 May 2026.

로킷헬스케어: what insiders have been doing

로킷헬스케어 belongs to the Health Care sector. Filings by its managers are published through DART (FSS). Over the twelve months to 1 November 2026, 6 filings were filed, from 6 insiders.

Purchases and sales both appear in the filings: 3 purchases (3 insiders) and 2 sales (2 insiders). The totals do not cover 5 filings with an undisclosed amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Those buying include 2 chief executives and 1 board member.

The clock since the last published purchase (21 May 2026) now reads 173 days.

For context, the typical company on the same exchange (median of 2,655 companies) published 7 filings over the same period, against 6 filings here. Since 2026, the database holds 3 purchases and 2 sales by insiders of the company.

Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and UCB. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.

Insider Decl.
6
Thresholds
n/a
Buy Volume
€1M
3 ops. · all time
Sell Volume
€1M
2 ops. · all time

Who traded when

BuySale
길윤기1 sale
유석환1 sale
이민구1 buy
이영일1 buy
정철화1 buy

Since the insiders bought

  • Filed 06 Apr 2026 · 218 days ago · €431k
    -83.2%
    Entry ₩99,800 · Close 30 Oct 2026 ₩16,810

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Fundamental score
Ranked 22,878 of 26,911 companies
26.5
score / 100
Value
26
Quality
27
FCF yld-5.1%
Earn yld-0.8%
EV/EBITDA·
ROE-64%
Gross mgn60%
Net mgn-11%
Debt/EBITDA7.6x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

₩21,800
Analyst consensus
·
Income statement
Revenue₩26.2B
Gross profit₩15.7B60% margin
EBITDA₩3.5B13% margin
Net income-₩2.8B-38.7% margin
Balance sheet & cash
Market cap₩345.1B
Total debt₩26.2B
Free Cash Flow-₩17.8B
Debt / Equity82%
Profitability & ownership
ROE-64.4%
ROA-14.6%
% insiders23.5%
% institutions3.9%
Last declaration on 21 May 2026
Declarations9 total
  • ▼
    Executives
    €580kest.0DART
    19,450 sharesKRXDART:20260521000680
  • ▼
    부사장Executives(filed)
    €596kest.0DART
    20,000 sharesShareKRXDART:20260521000703
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • ▲
    사장Executives(filed)
    €596kest.0DART
    20,000 sharesShareKRXDART:20260521000718
    Canonical exit: 19 Aug 2026 (T+90)
  • ▲
    사장Executives(filed)
    €45kest.0DART
    1,500 sharesShareKRXDART:20260521000712
    Canonical exit: 19 Aug 2026 (T+90)
  • ▲
    사외이사Executives
    €431kest.0DART
    6,000 sharesShareKRXDART:20260406002478
    Canonical exit: 29 Jun 2026 (T+90)
  • ●
    Executives
    Executives(filed)
    0DART

9 of 9 declarations

About 로킷헬스케어

로킷헬스케어 is a company specializing in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative technologies to enhance healthcare.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations